Viscous Fibre Blend
Dietary SupplementHigh viscosity viscous fiber blend sprinkled on wheat and maize bran cereals(Bran Buds®; Kellogg Company)
NCT Number: NCT03741621
To investigate the role of fibre viscosity (low, medium, high) in lowering cholesterol in healthy individuals
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Phase 2
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
-healthy individuals
Exclusion criteria
High viscosity viscous fiber blend sprinkled on wheat and maize bran cereals(Bran Buds®; Kellogg Company)
Bran Buds cereal (white bran and maize bran) with psyllium (Bran Buds® with PSY; Kellogg Company)
All Bran cereal (All Bran®; Kellogg Company)
Time frame: change from baseline after 21 days, relative to control
Time frame: change from baseline after 21 days, relative to control
Time frame: change from baseline after 21 days, relative to control
Time frame: change from baseline after 21 days, relative to control
Time frame: change from baseline after 21 days, relative to control
Time frame: change from baseline after 21 days, relative to control
Unity Health Toronto
Other
Viscosity Rather Than Quality of Dietary Fibre Predicts Cholesterol-lowering Effect in Healthy Individuals
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04063137
Dyslipidemias, Glucose Metabolism Disorders
Singapore
View Trial DetailsNCT05729659
Dyslipidemias, Hyperlipidemias
Trikala, Thessaly, Greece
View Trial DetailsNCT02907112
Dyslipidemias, Hyperlipidemias
Nottingham, Notts, United Kingdom
View Trial DetailsNCT06305559
Arterial Occlusive Diseases, Arteriosclerosis
Hialeah, Florida, United States
View Trial Details